Clinical Cancer Drugs,volume 4,issue 1  (05-2017)

Period of time： 2017年1期

Publisher： Bentham Science Publishers

Founded in： 2014

Total resources： 8

E-ISSN： 2212-6988|4|1

ISSN： 2212-697x

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Clinical Cancer Drugs,volume 4,issue 1

Menu

Meet Our Editor-in-Chief

Clinical Cancer Drugs,volume 4,issue 1 , Vol. 4, Iss. 1, 2017-05 , pp. 1-1

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

MicroRNA: A Multi-Facet Biological Target for Cancer and Other Diseases

Clinical Cancer Drugs,volume 4,issue 1 , Vol. 4, Iss. 1, 2017-05 , pp. 2-9

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Nitrogen Mustards: The Novel DNA Alkylator

Clinical Cancer Drugs,volume 4,issue 1 , Vol. 4, Iss. 1, 2017-05 , pp. 10-46

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The PI3K/AKT/mTOR-Signal Transduction Pathway as Drug Target in Triple-Negative Breast Cancer

Clinical Cancer Drugs,volume 4,issue 1 , Vol. 4, Iss. 1, 2017-05 , pp. 47-58

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Dexamethasone for the Prevention of Cisplatin-induced Ototoxicity

Clinical Cancer Drugs,volume 4,issue 1 , Vol. 4, Iss. 1, 2017-05 , pp. 59-64

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Meningioma in an Elderly Presenting as Psychosis: A Case Report

Clinical Cancer Drugs,volume 4,issue 1 , Vol. 4, Iss. 1, 2017-05 , pp. 65-68

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Prevalence of Neuropathy Associated With Bortezomib: A Retrospective Study

Clinical Cancer Drugs,volume 4,issue 1 , Vol. 4, Iss. 1, 2017-05 , pp. 69-72

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 7 item(s)